Covaris Announces Supply and Distribution Agreement with Applied Biosystems
News Nov 14, 2007
Covaris Incorporated has announced that it has entered into a supply and distribution agreement with Applied Biosystems. As part of the agreement, Applied Biosystems will sell and support Covaris™ S2 sample preparation instrument system for use with Applied Biosystems' recently launched next-generation genetic analysis platform, the SOLiD™ System.
According to Covaris, its sample preparation technology, which is based on its patented Adaptive Focused Acoustic™ technology, brings speed and efficiency to biological and chemical sample preparation.
The Covaris technology accelerates next-generation DNA sequencing sample preparation. The technology involves bead handling, and fragment and mate- pair library compilation to accelerate bead reaction and DNA shearing, which enables the generation of up to 35 base pairs of sequence data.
"Our relationship with Covaris has helped us to develop the most robust, accurate, and highest-throughput genetic analysis platform in the marketplace today to help our customers take advantage of the emerging applications for next-generation DNA sequencing," said Kim Caple, vice president and general manager for Applied Biosystems' next-generation sequencing business.
According to Jim Laugharn, President and CEO of Covaris, "This agreement reflects the fundamental benefits the Covaris technology has for biological and chemical sample processing. For example, this versatile instrument can be used for both high intensity shearing of genomic DNA with one sample and for controlled, gentle mixing of enzymatic reaction beads in the next sample.
"Partnering with a life sciences industry leader such as Applied Biosystems enables Covaris to continually bring advanced tools to the market," said Laugharn.
Genome-wide association studies (GWAS) look at large populations to find genes that contribute to common, multi-gene traits like height or obesity. These comprehensive studies frequently turn up large numbers of tiny genetic variations that occur more often in people who are tall, obese, etc. So which genes should scientists investigate further?READ MORE
In recent years, numerous studies have shown that people who don't get enough sleep are at greater risk of stroke and heart attack. A study found that people who sleep fewer than 7 hours per night have lower blood levels of three physiological regulators, or microRNAs, which influence gene expression and play a key role in maintaining vascular health.